Jatenzo: Immunomodulatory Therapy for Allergic Rhinitis and Asthma in Hypogonadal US Males
Reading Time: 2 minutesIntroduction Allergic rhinitis and asthma represent significant public health challenges in the United States, disproportionately affecting American males aged 18-65. According to the Centers for Disease Control and Prevention (CDC), over 25 million adults suffer from asthma, with men experiencing higher rates of severe exacerbations linked to occupational exposures and hormonal imbalances. Jatenzo (testosterone undecanoate) oral capsules, approved by the... Read more »
